Dexcom | DXCM - 债务利息支出

金融业

USD 79.41

USD 6.24B

现金及等价物

USD 961.4M

USD 478.4M

USD 3.92B

USD 2.25B

USD 1.24B

USD 318.3M

USD 435.2M

10.3K

EPS每股收益

USD 0.73

股本和储备

USD 2.54B

USD 864.4M

债务利息支出

USD 3.1M

USD 16.9M

USD 1.3B

USD 32.02B

USD 249.1M

USD 990.1M

USD 318.3M

普通股股本

USD 377.4M

31.31

USD 317.5M

USD 1.34B

销售和管理费用

USD 358.7M

USD 770.7M

贸易债权人

USD 2.08B

应收帐款人

USD 1.27B

	债务利息支出	更改		日
Abbott	USD 297M		2M	2026-09
Align Technology	USD 9.96M		3.02M	2026-06
AtriCure	USD 1.2M		15K	2026-06
Baxter International	USD 64M		14M	2026-06
Becton, Dickinson and Co.	USD 130M		2M	2026-09
Boston Scientific	USD 100M		4M	2026-09
Cooper Companies	USD 21.5M		600K	2026-06
Dexcom	USD 3.1M		100K	2026-09
Edwards Lifesciences	USD 30M		5.9M	2026-06
Globus Medical	USD 5.53B		39.93M	2026-09
Inogen	1.03M		384K	2025-03
Insulet	USD 12.3M		1.3M	2026-09
Integra LifeSciences	USD 22.96M		33K	2026-09
J&J	USD 43M		25M	2026-03
Medtronic	USD 186M		10M	2026-06
Merit Medical Systems	USD 7.33M		4.78M	2026-09
Roche Holding	CHF 304M		7.5M	2025-06
Solventum Corp	USD 14.16B		78M	2026-09
Stryker	USD 47.25B		683M	2026-09
Tandem Diabetes Care	USD 1.16B		5.29M	2026-09
Teleflex	USD 21.21M		6.75M	2026-09
West Pharmaceutical Services	USD 3.8M		1.2M	2026-09
Zimmer Biomet Holdings	USD 23.54B		740.8M	2026-09